Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 2Phase NA 1Phase 3 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 11Pancreatic Neoplasms 7Rectal Neoplasms 6Neoplasms 3Colorectal Neoplasms 3Stomach Neoplasms 2Solid Tumors 1Obesity 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Locally Advanced Rectal Cancer 1Klatskin Tumor 1Hypopharyngeal Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Cholangitis, Sclerosing 1Carcinoma, Hepatocellular 1Capecitabine 1Biliary Tract Neoplasms 1Anus Neoplasms 1Adenocarcinoma 1

Interventions

irinotecan sucrosofate 1Oxaliplatin 1Fluorouracil 1Diathermy 1Combined Modality Therapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Locally Advanced Rectal Cancer × Capecitabine × Clear all
NCT06894797 2025-03-25

Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.

Peking University Cancer Hospital & Institute

Phase NA Recruiting
68 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡